Navuridine is an experimental antiviral drug that functions as a nucleoside analogue, designed to inhibit HIV reverse transcriptase. It showed promising antiviral activity in lab and animal studies, but due to its short half-life and poor oral bioavailability, it was never developed for clinical use. It is grouped under the following drug class(es): Nucleosides. The directory classifies it as a clinical API with a synthetic source/manufacturing origin. Other names for this substance include navuridinum and 3′-azido-2′-3′-dideoxyuridine. Its PubChem CID is 55262.
Navuridine
| CAS No | 84472-85-5 |
|---|---|
| Molecular Formula | C9H11N5O4 |
| Molecular Weight | 253.22 g/mol |
| Synonyms | 1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Navuridine is an experimental antiviral drug that functions as a nucleoside analogue, designed to inhibit HIV reverse transcriptase. It showed promising antiviral activity in lab and animal studies, but due to its short half-life and poor oral bioavailability, it was never developed for clinical use.
The listed CAS number is 84472-85-5.
The listed molecular formula is C9H11N5O4.
The listed molecular weight is 253.22 g/mol.
1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione.
The source lists navuridinum and 3'-azido-2'-3'-dideoxyuridine.